An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study

Diabetes Research and Clinical Practice

Volumn 106, Issue 2, 2014, Pages 247-255

  Blackberry, Irene D ^a   Furler, John S ^a   Ginnivan, Louise E ^a   Manski Nankervis, Jo Anne ^a   Jenkins, Alicia ^a   Cohen, Neale ^b   Best, James D ^c   Young, Doris ^a   Liew, Danny ^a   Ward, Glenn ^d   O'Neal, David N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Insulin; Primary care; Retrospective continuous glucose monitoring; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; INSULIN GLARGINE; INSULIN GLULISINE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; ANTIDIABETIC AGENT; GLARGINE; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; LONG ACTING INSULIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DISEASE DURATION; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; GENERAL PRACTICE; GENERAL PRACTITIONER; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; PRIMARY MEDICAL CARE; SCREENING; ANALOGS AND DERIVATIVES; ANALYSIS; BLOOD; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FEASIBILITY STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE; POSTPRANDIAL STATE; PRIMARY HEALTH CARE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

ADULT; AGED; AUSTRALIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POSTPRANDIAL PERIOD; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84920665041     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.08.011     Document Type: Article

References (32)

1. Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence in adults for 2013 and projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract 2014, 103(2):137-149.
2. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321(7258):405-412.
3. Penfornis A., San-Galli F., Cimino L., Huet D. Current insulin therapy in patients with type 2 diabetes: results of the ADHOC survey in France. Diabetes Metab 2011, 37(5):440-445.
4. Rubino A., McQuay L.J., Gough S.C., Kvasz M., Tennis P. Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK. Diabet Med 2007, 24(12):1412-1418.
5. Costi M., Dilla T., Reviriego J., Castell C., Goday A. Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain. Acta Diabetol 2010, 47(Suppl. 1):169-175.
6. Davis T.M.E., Davis W.A., Bruce D.G. Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes Study. Med J Australia 2006, 184(7):325-328.
7. Polinski J.M., Connolly J.G., Curtis B.H., Seeger J.D., Gaskins K., Perez M., et al. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review. Prim Care Diabetes 2013, 22(13):148-154.
8. Blak B.T., Smith H.T., Hards M., Maguire A., Gimeno V. A retrospective database study of insulin initiation in patients with Type 2 diabetes in UK primary care. Diabet Med 2012, 29(8). e191-8.
9. Polonsky W.H., Fisher L., Guzman S., Villa-Caballero L., Edelman S.V. Psychological insulin resistance in patients with Type 2 diabetes: the scope of the problem. Diabetes Care 2005, 28(10):2543-2545.
10. Parchman M.L., Pugh J.A., Romero R.L., Bowers K.W. Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin. Ann Fam Med 2007, 5(3):196-201.
11. AIHW Australian GP Statistics and Classification Centre, SAND abstract No. 135 from the BEACH program: Diabetes in general practice patients 2009, AGPSCC University of Sydney, Sydney.
12. Waddingham S. Time to start insulin in general practice. Br J Prim Care Nurs 2012, 9(3):114-117.
13. Blak B.T., Smith H.T., Hards M., Curtis B.H., Ivanyi T. Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin. Diabet Med 2012, 29(7):13-20.
14. Department of Health and Ageing Towards a National Primary Health Care Strategy: A Discussion Paper from the Australian Government 2008, Canberra.
15. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil H.A.W. 10-year follow-up of intensive glucose control in Type 2 diabetes. N Engl J Med 2008, 359(15):1577-1589.
16. Blackberry I., Furler J., Ginnivan L., Derraz H., Jenkins A., Cohen N., et al. An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol. BMC Fam Practice 2014, 15:82.
17. Furler J.S., Blackberry I.D., Walker C., Manski-Nankervis J.A., Anderson J., O'Neal D., et al. Stepping up: a nurse-led model of care for insulin initiation for people with type 2 diabetes. Fam Pract 2014, 28:28.
18. Craig P., Dieppe P., Macintyre S., Michie S., Nazareth I., Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337(337):pa1655.
19. ® Health Survey 2003, QualityMetric Incorporated, Lincoln, RI.
20. Wee H., Tan C., Goh S., Li S. Usefulness of the Audit of Diabetes-Dependent Quality-of-Life (ADDQoL) questionnaire in patients with diabetes in a multi-ethnic Asian country. Pharmacoeconomics 2006, 24(7):673-682.
21. Scott R., Best J., Forder P., Taskinen M.R., Simes J., Barter P., et al. Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]. Cardiovasc Diabetol 2005, 4(13):13.
22. Hayes R.P., Fitzgerald J.T., Jacober S.J. Primary care physician beliefs about insulin initiation in patients with Type 2 diabetes. Int J Clin Pract 2008, 62(6):860-868.
23. Fox L.A., Beck R.W., Xing D. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010, 33(6):1297-1299.
24. Australian Medicare Local Alliance General Practice Nurse National Survey 2012 2012, Australian Medicare Local Alliance, Manuka.
25. Poolsup N., Suksomboon N., Kyaw A.M. Systematic review and meta-analysis of the effectiveness of continuous glucose monitoring (CGM) on glucose control in diabetes. Diabetol Metab Syndr 2013, 5(1):39.
26. O'Connell M.A., Donath S., O'Neal D.N., Colman P.G., Ambler G.R., Jones T.W., et al. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial. Diabetologia 2009, 52(7):1250-1257.
27. Bergenstal R.M., Tamborlane W.V., Ahmann A., Buse J.B., Dailey G., Davis S.N., et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010, 363(4):311-320.
28. Davis T.M., Clifford R.M., Davis W.A. Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study. Diabetes Res Clin Pract 2001, 52(1):63-71.
29. Manning J., Halford J., Sulik B., Sulik M., Parkin C., Liljenquist D. Use of Continuous Glucose Monitoring is acceptable and potentially beneficial in older T2DM patients treated with basal insulin therapy: a pilot study. Infusystem USA 2014, 11(1):1-5.
30. Polonsky W., Fisher L., Schikman C., Hinnen D., Parkin C., Jelsovsky Z. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 2011, 34(2):262-267.
31. Maurizi A.R., Pozzilli P. Do we need continuous glucose monitoring in type 2 diabetes?. Diabetes Metab Res Rev 2013, 24(10).
32. Arnolds S., Heise T., Flacke F., Sieber J. Common standards of basal insulin titration in type 2 diabetes. J Diabetes Sci Technol 2013, 7(3):771-788.